Skip to content

A study of risk factors associated with the development of atrial fibrillation in patients with primary aldosteronism

A study of risk factors associated with the development of atrial fibrillation in patients with primary aldosteronism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400083407
Enrollment
Unknown
Registered
2024-04-24
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary aldosteronism

Interventions

Observation group :None

Sponsors

The First Affiliated Hospital of Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients were =18 years old, and sex was not limited; (2) Patients who met the diagnostic and treatment guidelines for primary aldosteronism and who met the diagnostic criteria for primary aldosteronism after strict drug elution; (3) Blood pressure conditions met one of the following conditions: office blood pressure =140/90 mmHg; ambulatory blood pressure monitoring: all-day blood pressure >130/80 mmHg or daytime blood pressure >135/85 mmHg; (4) Adrenal CT showing adrenal hyperplasia, nodules, or no obvious morphological abnormalities; (5) Patients or their legal representatives signed a written informed consent form approved by the ethics committee before screening.

Exclusion criteria

Exclusion criteria: (1) Patients with primary hypertension or secondary hypertension from other causes; (2) Women who are pregnant, breastfeeding or have plans to have children in the next year; (3) Patients with serious organic diseases, especially liver and kidney dysfunction; (4) Severe allergy to contrast media; (5) Patients with other severe organic diseases with a life expectancy of <12 months; (6) The patient has been enrolled or wishes to participate in other clinical studies. During the enrollment period, the results of this study will be affected; (7) According to the judgment of the investigator, the study was considered unsuitable for any reason.

Design outcomes

Primary

MeasureTime frame
24-hour ambulatory blood pressure;24-hour ambulatory electrocardiogram;

Secondary

MeasureTime frame
Carotid intima-media thickness;Pulse wave velocity;Ankle brachial blood pressure index;left ventricular hypertrophy;Estimated glomerular filtration rate;Microalbuminuria;Urine Albumin to Creatinine Ratio;

Countries

China

Contacts

Public ContactWang Peijian

The First Affiliated Hospital of Chengdu Medical College

wpjmed@aliyun.com+86 189 8071 8263

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026